Our Mission
Join us & help patients suffering today.
“We will research, develop and make available commercially effective and affordable plant-based cannabinoid medicines specifically for treating patients suffering from cancer related pain in the UK.”
Graeme McFarlane, Chief Executive Officer
About us
Research
Investors
Media
Contact
Real World Evidence
Multidimensional Evidence Generation and FDA Regulatory Decision Making
Real World Evidence
Interpretation and Impact of Real-World Clinical Data for the Practicing Clinician
Real World Evidence
The Expanding Role of Real-World Evidence Trials in Health Care Decision Making
Real World Evidence
Can real-world data really replace randomised clinical trials?
Real World Evidence
Modernizing Regulatory Evidence with Trials and Real-World Studies
Real World Evidence
Our Team
Meet our expert team.
A diverse team with extensive experience in the pharmaceutical, regulation and finance sectors
Learn about our Management Team
Prof. Mike Bewick
Chief Clinical Advisor
Prof. Saoirse O’Sullivan
Cinical Advisor
Prof. Sam Ahmedzai
Clinical Advisor
Prof. Mike Bennett
Cinical Advisor
Dr. Barry Laird
Cinical Advisor
Dr. Paul Farquhar-Smith
Cinical Advisor
Rob Kang
Chief Financial Officer
Shaheen Bhimani
Chief Operating Officer
Rocky Dhaliwal
Chief Engineering Officer
Talk to us
Need more details? Contact us.
A diverse team with extensive experience in the Canadian and Californian cannabis market, public company management, Agri-Tech and European pharmaceutical patient access.
